Vicapsys Life Sciences, Inc. (VICP)
USD 7.0
(0.0%)
USD 7.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -417.52 Thousand | -238.19 Thousand | -443.97 Thousand | -262.89 Thousand | -970.26 Thousand | -2.08 Million |
| Net Income | -1.18 Million | -984.79 Thousand | -236.87 Thousand | -765.84 Thousand | -1.03 Million | -1.28 Million |
| Depreciation & Amortization | 115.08 Thousand | 31.28 Thousand | 31.32 Thousand | 31.42 Thousand | 31.29 Thousand | 126.84 Thousand |
| Deferred income taxes | - | - | - | 263.8 Thousand | - | - |
| Stock-based compensation | 20.69 Thousand | 105.65 Thousand | 4326.00 | 14.78 Thousand | 118.64 Thousand | - |
| Change in working capital | 628.8 Thousand | 269.42 Thousand | -142.75 Thousand | 456.74 Thousand | 46.52 Thousand | -68.44 Thousand |
| Other non-cash items | 115.08 Thousand | 340.23 Thousand | -100 Thousand | -263.8 Thousand | -132.83 Thousand | -524.85 Thousand |
| Investing Cash Flow | - | - | 100 Thousand | - | - | -38.01 Thousand |
| Investments in PPE | 3.00 | -3.00 | - | - | - | - |
| Acquisitions | - | - | 100 Thousand | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 100 Thousand | - | - | - |
| Other Investing Activities | - | - | -100 Thousand | - | - | -38.01 Thousand |
| Financing Cash Flow | 412.84 Thousand | 34.99 Thousand | 560 Thousand | - | 1.14 Million | 1.66 Million |
| Debt repayment | -262.4 Thousand | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 100 Thousand | 34.99 Thousand | 560 Thousand | - | 971.5 Thousand | 1.48 Million |
| Other Financing Activities | 50.44 Thousand | 34.99 Thousand | 560.00 | - | 176.6 Thousand | 176.49 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 591.65 Thousand | 271.4 Thousand | -137.26 Thousand | 341.43 Thousand | 46.52 Thousand | -83.95 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 37.15 Thousand | -1985.00 | -5498.00 | 115.31 Thousand | - | 292.59 Thousand |
| Cash at beginning of period | 14.09 Thousand | 217.29 Thousand | 1269.00 | 264.16 Thousand | 86.33 Thousand | 547.59 Thousand |
| Cash at end of period | 9422.00 | 14.09 Thousand | 217.29 Thousand | 1269.00 | 264.16 Thousand | 86.33 Thousand |
| Capital Expenditure | 3.00 | -3.00 | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -4675.00 | -203.19 Thousand | 216.02 Thousand | -262.89 Thousand | 177.83 Thousand | -461.26 Thousand |
| Free Cash Flow | -417.52 Thousand | -238.2 Thousand | -443.97 Thousand | -262.89 Thousand | -970.26 Thousand | -2.08 Million |
| Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -594.8 Thousand | -240.33 Thousand | -135.69 Thousand | -211.27 Thousand | -492.6 Thousand | -984.79 Thousand |
| Depreciation & Amortization | - | 62.24 Thousand | - | - | 7821.00 | 31.28 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | 20.69 Thousand | 62.09 Thousand | 105.65 Thousand |
| Change in working capital | 461.3 Thousand | 52.03 Thousand | -65.15 Thousand | 180.62 Thousand | 85.34 Thousand | 269.42 Thousand |
| Other non-cash items | 51.44 Thousand | 80.89 Thousand | -17.25 Thousand | -161.15 Thousand | 340.23 Thousand | 340.23 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | 3.00 | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 37.94 Thousand | -70.33 Thousand | 445.24 Thousand | - | -15 Thousand | 34.99 Thousand |
| Debt repayment | -64.73 Thousand | -18.1 Thousand | -345.24 Thousand | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 100 Thousand | - | -15 Thousand | 34.99 Thousand |
| Other Financing Activities | 102.67 Thousand | -52.23 Thousand | 690.48 Thousand | - | -15 Thousand | 34.99 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 379.35 Thousand | 26.53 Thousand | 3914.00 | 181.85 Thousand | 83.29 Thousand | 271.4 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 81.94 Thousand | 25.5 Thousand | -69.06 Thousand | -1229.00 | 2055.00 | -1985.00 |
| Cash at beginning of period | 53.53 Thousand | 231.27 Thousand | 4140.00 | 14.09 Thousand | 26.21 Thousand | 217.29 Thousand |
| Cash at end of period | 9422.00 | 53.53 Thousand | 231.27 Thousand | 4140.00 | 14.09 Thousand | 14.09 Thousand |
| Capital Expenditure | - | 3.00 | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -44.11 Thousand | -177.74 Thousand | 227.13 Thousand | -9957.00 | -12.11 Thousand | -203.19 Thousand |
| Free Cash Flow | -82.05 Thousand | -107.4 Thousand | -218.1 Thousand | -9957.00 | 2888.00 | -238.19 Thousand |
0K6O
PNCINFRA
UUGWF
CDXI
BYRN
SB-PD